Inactivation of Apc in the mouse prostate causes prostate carcinoma
- PMID: 17363566
- DOI: 10.1158/0008-5472.CAN-06-3028
Inactivation of Apc in the mouse prostate causes prostate carcinoma
Abstract
Alterations of the Wnt/beta-catenin signaling pathway are positively associated with the development and progression of human cancer, including carcinoma of the prostate. To determine the role of activated Wnt/beta-catenin signaling in mouse prostate carcinogenesis, we created a mouse prostate tumor model using probasin-Cre-mediated deletion of Apc. Prostate tumors induced by the deletion of Apc have elevated levels of beta-catenin protein and are highly proliferative. Tumor formation is fully penetrant and follows a consistent pattern of progression. Hyperplasia is observed as early as 4.5 weeks of age, and adenocarcinoma is observed by 7 months. Continued tumor growth usually necessitated sacrifice between 12 and 15 months of age. Despite the high proliferation rate, we have not observed metastasis of these tumors to the lymph nodes or other organs. Surgical castration of 6-week-old mice inhibited tumor formation, and castration of mice with more advanced tumors resulted in the partial regression of specific prostate glands. However, significant areas of carcinoma remained 2 months postcastration, suggesting that tumors induced by Apc loss of function are capable of growth under conditions of androgen depletion. We conclude that the prostate-specific deletion of Apc and the increased expression of beta-catenin associated with prostate carcinoma suggests a role for beta-catenin in prostate cancer and offers an appropriate animal model to investigate the interaction of Wnt signaling with other genetic and epigenetic signals in prostate carcinogenesis.
Similar articles
-
APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.Gastroenterology. 2006 Oct;131(4):1096-109. doi: 10.1053/j.gastro.2006.08.011. Epub 2006 Aug 16. Gastroenterology. 2006. PMID: 17030180
-
Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.Cancer Res. 2007 May 1;67(9):4079-87. doi: 10.1158/0008-5472.CAN-06-4025. Cancer Res. 2007. PMID: 17483318
-
Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.Oncogene. 2003 Jun 19;22(25):3875-87. doi: 10.1038/sj.onc.1206426. Oncogene. 2003. PMID: 12813461
-
Androgen action during prostate carcinogenesis.Methods Mol Biol. 2011;776:25-44. doi: 10.1007/978-1-61779-243-4_2. Methods Mol Biol. 2011. PMID: 21796518 Review.
-
Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.J Cell Biochem. 2005 Feb 1;94(2):279-97. doi: 10.1002/jcb.20339. J Cell Biochem. 2005. PMID: 15565647 Review.
Cited by
-
Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.Cancer Res. 2013 May 1;73(9):2718-36. doi: 10.1158/0008-5472.CAN-12-4213. Epub 2013 Apr 22. Cancer Res. 2013. PMID: 23610450 Free PMC article.
-
Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression.Oncotarget. 2017 May 17;8(46):80265-80277. doi: 10.18632/oncotarget.17919. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113300 Free PMC article.
-
Wnt/β-catenin signalling in prostate cancer.Nat Rev Urol. 2012 Aug;9(8):418-28. doi: 10.1038/nrurol.2012.116. Epub 2012 Jun 19. Nat Rev Urol. 2012. PMID: 22710668 Review.
-
Molecular genetics of prostate cancer: new prospects for old challenges.Genes Dev. 2010 Sep 15;24(18):1967-2000. doi: 10.1101/gad.1965810. Genes Dev. 2010. PMID: 20844012 Free PMC article. Review.
-
CD4+ lymphocytes modulate prostate cancer progression in mice.Int J Cancer. 2009 Aug 15;125(4):868-78. doi: 10.1002/ijc.24452. Int J Cancer. 2009. PMID: 19408303 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases